Inflammatory bowel disease (IBD)

HKB's Mouse Inflammatory Bowel Disease Models provide pharmaceutical researchers with robust platforms for developing Crohn's disease and ulcerative colitis therapeutics. Our portfolio includes chemically-induced models (DSS, TNBS, oxazolone), genetic models (IL-10 knockout, T cell transfer), and humanized models representing various IBD phenotypes.